Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Wapnick Pamela sold 2,884 Metagenomi Therapeutics, Inc. shares (Form 4)
Traded Jun 5, 2026 · Filed Jun 10, 2026
On Jun 5, 2026, Wapnick Pamela (Chief Financial Officer) sold 2,884 Metagenomi Therapeutics, Inc. shares at US$1.30 for US$3,749, leaving 208,491 shares. Filed Jun 10, 2026 (Form 4).
- Sold
- 2,884 shares
- Price
- US$1.30
- Value
- US$3,749
- Holding after
- 208,491 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Sale | 2,884 | US$1.30 | 208,491 | Direct |
Source
Related
- Metagenomi Therapeutics, Inc.
- Wapnick Pamela
- Metagenomi Therapeutics, Inc. shareholders
- Form 4 · Wapnick Pamela · Sep 10, 2026
- Form 4 · Wapnick Pamela · Apr 3, 2026
- Form 4 · Reid Laurence · Sep 11, 2026
- Form 4 · Wein Matthew · Sep 10, 2026
- Form 4 · Irish Jian · Sep 10, 2026
- Schedule 13G · Thomas Brian C. · Sep 10, 2026
- Form 4 · Irish Jian · Jun 10, 2026